Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina

Experimental Eye Research

Volumn 69, Issue 3, 1999, Pages 331-342

  Osborne, N N ^a   Desantis, L ^b   Bae, J H ^a   Ugarte, M ^a   Wood, J P M ^a   Nash, M S ^a   Chidlow, G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ALCON RESEARCH LTD   (United States)

Author keywords

NMDA Toxicity, ischaemia; Retina, ganglion cells, neuroprotection, betaxolol

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETAXOLOL; CHOLINE ACETYLTRANSFERASE; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAM; IMMUNOHISTOCHEMISTRY; INTRAVITREAL DRUG ADMINISTRATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; RETINA ISCHEMIA; TOPICAL DRUG ADMINISTRATION;

EID: 0032879302     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1999.0706     Document Type: Article

References (58)

1. Akaike N., Ito H., Nishi K., Oyama Y. Further analysis of inhibitory effects of propranolol and local anaesthetics on the calcium current in Helix neurones. Br. J. Pharmacol. 76:1982;37-43.
2. Anderson J. Systemic absorption of topical ocularly applied epinephrine and dipivefrin. Arch Ophthalmol. 98:1980;350-353.
3. 2+channel blocker omega-agatoxin IVA protects against brain injury after focal ischemia in rats. Brain Res. 776:1997;140-145.
4. Block F., Schwarz M. The b-wave of the electroretinogram as an index of retinal ischemia. Gen. Pharmacol. 30:1998;281-287.
5. Bonne C., Muller A., Villain M. Free radicals in retinal ischemia. Gen. Pharmacol. 30:1998;275-280.
6. Bowersox S. S., Singh T., Luther R. R. Selective blockade of N -type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in rats. Brain Res. 747:1997;343-347.
7. Brandstatter J. H., Hartveit E., Sassoe Pognetto M., Wassle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur. J. Neurosci. 6:1994;1100-1112.
8. Buchi E. R. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Exp. Eye Res. 55:1992;605-613.
9. Buckley M. M., Goa K. L., Clissold S. P. Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension. Drugs. 40:1990;75-90.
10. Burnet P. W., Eastwood S. L., Harrison P. J. Detection and quantitation of 5-HT1A and 5-HT2A receptor mRNAs in human hippocampus using a reverse transcriptase-polymerase chain reaction (RT-PCR) technique and their correlation with binding site densities and age. Neurosci. Lett. 178:1994;85-89.
11. Cao W., Zaharia M., Drumheller A., Casanova C., Lafond G., Brunette J. R., Jolicoeur F. B. Effects of dextromethorphan on ischemia induced electroretinogram changes in rabbit. Curr. Eye Res. 13:1994;97-102.
12. Carenini B. B., Brogliatti B. Intraocular pressure as a risk factor in glaucoma. Bucci M. G. Glaucoma: decision making in therapy. 1996;9-14 Springer.
13. Cavicchioli L., Flanigan T. P., Dickson J. G., Vantini G., Dal Toso R., Fusco M., Walsh F. S., Leon A. Choline acetyltransferase messenger RNA expression in developing and adult rat brain: regulation by nerve growth factor. Brain Res. Mol. Brain Res. 9:1991;319-325.
14. Choi D. W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:1995;58-60.
15. DeSantis L, Dahlin D., Barnes G. A role for the calcium channel blocking-like action of betaxolol for providing therapeutic benefit to glaucoma patients. Drance S. M. Update to glaucoma, ocular blood flow and drug treatment. 1995;137-143 Kugler, Amsterdam.
16. Dreyer E. B., Pan Z. H., Storm S., Lipton S. A. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport. 5:1994;629-631.
17. 2+channels in mammalian central neurons. Trends Neurosci. 18:1995;89-98.
18. Ferrari Dileo G. Beta 1 and beta 2 adrenergic binding sites in bovine retina and retinal blood vessels. Invest. Ophthalmol. Vis. Sci. 29:1988;695-699.
19. Flammer J., Orgul S. Optic nerve blood-flow abnormalities in glaucoma. Prog. Retina Eye Res. 17:1998;267-289.
20. Gill E. W., Vaughan Williams E. M. Local anaesthetic activity of the β-receptor antagonist, pronethalol. Nature. 201:1964;199.
21. Hester R. K., Chen Z., Becker E. J., McLaughlin M., DeSantis L. The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery. Surv. Ophthalmol. 38 Suppl:1994;S125-34.
22. Hicks D., Heidinger V., Mohand Said S., Sahel J., Dreyfus H. Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia. Gen. Pharmacol. 30:1998;265-273.
23. Hoste A. M., Sys S. U. The relaxant action of betaxolol on isolated bovine retinal microarteries. Curr. Eye Res. 13:1994;483-487.
24. Ishida H., Sasa M., Takaori S. Local anesthetic activity of beta-adrenergic blocking drugs in the Crayfish giant axon, with reference to calcium ion. Jpn J. Pharmacol. 30:1980;607-619.
25. Kaiser H. J., Flammer J., Stumpfig D., Hendrickson P. Longterm visual field follow-up of glaucoma patients treated with beta-blockers. Surv. Ophthalmol. 38 Suppl:1994;S156-9; discussion S160.
26. Kristian T., Siesjo B. K. Calcium in ischemic cell death. Stroke. 29:1998;705-718.
27. Lam T. T., Siew E., Chu R., Tso M. O. Ameliorative effect of MK-801 on retinal ischemia. J. Ocul. Pharmacol. Ther. 13:1997;129-137.
28. Larsen A. K., Osborne N. N. Involvement of adenosine in retinal ischemia. Studies on the rat. Invest. Ophthalmol. Vis. Sci. 37:1996;2603-2611.
29. Lipton S. A., Nicotera P. Calcium, free radicals and excitotoxins in neuronal apoptosis. Cell Calcium. 23:1998;165-171.
30. Louzada Junior P., Dias J. J., Santos W. F., Lachat J. J., Bradford H. F., Coutinho Netto J. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 59:1992;358-363.
31. Mantyh P. W., Rogers S. D., Allen C. J., Catton M. D., Ghilardi J. R., Levin L. A., Maggio J. E., Vigna S. R. Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human. J. Neurosci. 15:1995;152-164.
32. Messmer C., Flammer J., Stumpfig D. Influence of betaxolol and timolol on the visual fields of patients with glaucoma. Am. J. Ophthalmol. 112:1991;678-681.
33. Mishima S. Clinical pharmacokinetics of the eye. Proctor lecture. Invest. Ophthalmol. Vis. Sci. 21:1981;504-541.
34. Mori T., Sugawara T., Hosobe Y., Gotoh T., Kato C., Tazawa Y. The effect of calcium antagonist on ischemia-reperfusion injury of the rabbit retina. Nippon Ganka Gakkai Zasshi. 100:1996;773-776.
35. Morizane C., Adachi K., Furutani I., Fujita Y., Akaike A., Kashii S., Honda Y. N(omega)-nitro-l-arginine methyl ester protects retinal neurons against N -methyl-d-aspartate-induced neurotoxicity in vivo. Eur. J. Pharmacol. 328:1997;45-49.
36. Nash M. S., Osborne N. N. Assessment of Thy-1 mRNA levels as an index for retinal ganglion cell damage. Invest. Ophthalmol. Vis. Sci. 40:1999;1293-1298.
37. 2+)-antagonist. Brain Res. 706:1996;289-292.
38. Osborne N. N. Neuroprotection to the retina: relevance in glaucoma. Drance S. M. Vascular risk factors and neuroprotection in glaucoma - Update 1996. 1997;139-155 Kugler, Amsterdam.
39. Osborne N. N. Memantine reduces alterations to the mammalian retina, in situ: induced by ischaemia. Vis. Neurosci. 16:1999;45-52.
40. Osborne N. N., Larsen A., Barnett N. L. Influence of excitatory amino acids and ischemia on rat retinal choline acetyltransferase-containing cells. Invest. Ophthalmol. Vis. Sci. 36:1995a;1692-1700.
41. Osborne N. N., Wood J., Muller A. The influence of experimental ischaemia on protein kinase C and the GABAergic system in the rabbit retina. Neuropharmacology. 34:1995b;1279-1288.
42. Osborne N. N., Larsen A. K. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure: effect of glutamate antagonists. Neurochem Int. 29:1996;263-270.
43. Osborne N. N., Cazevieille C., Carvalho A. L., Larsen A. K., DeSantis L. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res. 751:1997;113-123.
44. Osborne N. N., Chidlow G., Nash M. S., Wood J. P. M. The potential of neuroprotection in glaucoma treatment. Curr. Op. Ophthalmol. 10:1999;82-92.
45. Peng Y. W., Blackstone C. D., Huganir R. L., Yau K. W. Distribution of glutamate receptor subtypes in the vertebrate retina. Neuroscience. 66:1995;483-497.
46. Selles Navarro I., Villegas Perez M. P., Salvador Silva M., Ruiz Gomez J. M., Vidal Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest. Ophthalmol. Vis. Sci. 37:1996;2002-2014.
47. Setoguchi M., Ohya Y., Abe I., Fujishima M. Inhibitory action of betaxolol, a beta 1-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein. Br. J. Pharmacol. 115:1995;198-202.
48. Siegner S. W., Giovanoni R. L., Erickson K. A., Netland P. A. Distribution of verapamil and norverapamil in the eye and systemic circulation after topical administration of verapamil in rabbits. J. Ocul. Pharmacol. Ther. 14:1998;159-168.
49. Siliprandi R., Canella R., Carmignoto G., Schiavo N., Zanellato A., Zanoni R., Vantini G. N -methyl-d-aspartate-induced neurotoxicity in the adult rat retina. Vis. Neurosci. 8:1992;567-573.
50. Snedecor G. W., Cochran W. G. Levene's test. Statistical methods. 1980;Iowa State University. p. 253-4.
51. Sucher N. J., Lei S. Z., Lipton S. A. Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res. 551:1991;297-302.
52. Sugrue M. F. The pharmacology of antiglaucoma drugs. Pharmacol. Ther. 43:1989;91-138.
53. Takahashi K., Lam T. T., Edward D. P., Buchi E. R., Tso M. O. Protective effects of flunarizine on ischemic injury in the rat retina. Arch Ophthalmol. 110:1992;862-870.
54. Toris C. B., Camras C. B., Yablonski M. E. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes. Ophthalmology. 100:1993;1297-1304.
55. +channels: a rational and effective strategy against ischemic brain damage. Pharmacol. Rev. 48:1996;21-67.
56. Vorwerk C. K., Kreutz M. R., Dreyer E. B., Sabel B. A. Systemic l-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adult rats. Invest. Ophthalmol. Vis. Sci. 37:1996;2382-2392.
57. Yamamoto T., Kitazawa Y. Vascular pathogenesis of normal-tension glaucoma: a possible pathogenetic factor, other than intraocular pressure, of glaucomatous optic neuropathy. Prog. Retin. Eye Res. 17:1998;127-143.
58. Yoon Y. H., Marmor M. F. Dextromethorphan protects retina against ischemic injury in vivo. Arch Ophthalmol. 107:1989;409-411.